NYSDH approval enables Rosetta Genomics to offer its proprietary microRNA diagnostic for identification of four major subtypes of kidney cancer in all 50 US states.
Acquisition of leading regulatory firm in molecular diagnostics strengthens Illumina’s readiness for further expansion into clinical applications of next-generation sequencing.
The Appistry Pipeline Challenge will reward and support one winning proposal for a creative next-generation sequencing pipeline that will make a difference in clinical research and precision medicine.
TGI will build on transplant diagnostics patent rights co-owned by Northwestern University and the Scripps Research Institute to develop and commercialize genomics-based tests to improve organ transplant outcomes.
With recent action by the New York State Department of Health, CombiMatrix now markets two SNP-based genetic analysis tests in New York.
The latest from the AACC annual meeting and clinical lab expo—before, during, and after the event.
ACD’s easy-to-use RNAscope technology involved in more than 100 peer-reviewed papers in three years; company’s library of target probes exceeds 4,000.
Beckman Coulter has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics, including the MicroScan line of instruments and consumables.
bioMerieux sepsis facility expansion will help address the global public health threat of sepsis and meet the related demand for microbial detection.
Developer of the world’s first micro lab hires new leadership in preparation for clinical studies and commercialization.